Notable News

Update: Notable has raised $40 million, not the $50 million suggested by the original headline. Notable Labs, a Foster City, California-based provider of personalized drug combination testing for cancer patients, today revealed that it’s closed a $40 million series B round co-led by B Capital Group and LifeForce Capital, with participation from B Capital and […]

Since it raised its $10 million debut round in 2017, Notable Labs has been busy building its artificial-intelligence-based technology that predicts which types of patients are most likely to respond to a drug. Now, the startup is adding $40 million (PDF) to its reserves as it scales up its capabilities and plans to take its […]

SAN FRANCISCO, CA – July 16, 2019 – Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the traditional time and cost, announced a $40M Series B round. The round is co-led by B Capital Group and LifeForce Capital. LifeForce is a returning […]

Matt De Silva was working at Peter Thiel’s hedge fund, Clarium Capital, when he learned his father had three rare brain tumors. That discovery led De Silva to a deep dive into personalized cancer drug recommendations — and ultimately toward founding Notable Labs. The Foster City-based company pairs artificial intelligence software with flow cytometry lab […]

The feasibility study was meant to see whether personalized cancer genetic sequencing and drug sensitivity recommendations could be done in a “clinically reasonable amount of time.” The future of personalized cancer treatments will be enabled by technology to understand the genetic variants of a person’s disease, as well as tools to determine the best treatment […]

has brought on two biopharma executives to take charge of its clinical operations and drug development work. Incyte’s Hiroomi Tada joined as chief medical officer, while Aquinox’s Lloyd Mackenzie will serve as chief development officer. Tada was most recently vice president of targeted therapies and translational sciences at Incyte, where he helped guide the company’s […]

Notable Labs is donating commercial rights to price, manufacture and distribute pediatric leukemia drug to non­profit Cures Within Reach FOSTER CITY, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) ­­ Notable Labs, a startup that accelerates drug development by matching drugs with patients who are most likely to respond, announced today that it has launched its first […]

SAN DIEGO and FOSTER CITY, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) — Notable Labs, Inc., a mission-driven company aiming to transform the way cancer is treated, announced today that the Company and its collaborators will present results of their research at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition taking place December […]

Man & Woman of the Year is philanthropic competition to support blood cancer research among a group of motivated and dedicated individuals in communities across the United States. Candidates form powerful fundraising teams and compete in honor of two local children who are blood cancer survivors. The man and woman who have raised the most […]